9
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Chronic Fatigue Syndrome (CFS): A Critical Evaluation of Testing for Active Human Herpesvirus-6 (HHV-6) Infection

Review of Data of 107 Cases

, , &
Pages 3-16 | Published online: 04 Dec 2011

References

  • Hyde B. A bibliography of myalgic encephalomyelitis epidemics. The Nightingale Res Found 1991; 1:20–30.
  • Levine PH, Krueger GRF. The post-infectious chronic fatigue syndrome In: Ablashi DV, Faggioni A, Krueger GRF, Pagano J, Pearson GR. Epstein-Barr virus and human disease 1988. Clifton NJ: Humana Press, 1989, 405–38.
  • MeEvedy CP, Beard AW. Concept of benign myalgic encephalomyelitis. Brit Med J 1970; 1:11–5.
  • Ojo-Amaize EA, Conley EJ, Peter JB. Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome. Clin Infect Dis 1994; 18 Suppl 1:157–9.
  • WHO. The ICD-10 classification of mental and behavioral disorders. Clin-ical descriptions and diagnostic guide lines. Geneva: World Health Organization, 1992.
  • Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger AL, Straus SE, Jones JE, DeBois RE, Cunningham-Rundles C, Pahwa S, Tosato G, Zegan LS, Purtilo DT, Brown N, Schooley RI, Brus 1. Chronic fatigue syndrome, a working case definition. Ann Int Med 1988; 108:387–9.
  • Fock RRE, Krueger GRF. Chronic fatigue syndrome: Eine Standortbestim-mung. Dtsch Aerztebl 1994; 91:2946–53.
  • Jenkins R. Introduction. In: Jenkins R., Mowbray J. Postviral fatigue syn-drome (myalgic encephalomyelitis). Chichester: J Wiley Sons, 1991, 1–39.
  • Komaroff AL. Post-viral fatigue syndrome: a review of American research and practice. In: Jenkins R, Mowbray .1. Postviral fatigue syndrome (myalgic en-cephalomyelitis). Chichester: J Wiley Sons, 1991, 41–59.
  • Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff AL, Schluederberg A, Jones JF, Lloyd AR, Wessely S, Gantz NM, Holmes GP, Steele L, Reyes M, Abbey S, Rest J, Jolson H, Peterson DL, Vercoulen JHMM, Tirelli U, Evengard B, Natclson B, Reeves WC. Chronic fatigue syndrome: a comprehen-sive approach to its definition and study. Ann Intern Med 1994; 121:953–9.
  • Hoffmann A, Linder R, Kroeger B, Krueger GRF, Gross WL. The 1995 classification criteria for chronic fatigue syndrome. First World Congr Chronic Fatigue Syndrome, Brussels, Nov 9–11, 1995 (book of abstr): 7.
  • Ablashi DV, Zompetta C, Lease C, Josephs SF, Balachandra N, Komaroff AL, Krueger GRF, Henry B, Luka J, Salahuddin SZ. Human herpesvirus 6 (HHV-6) and chronic fatigue syndrome. Canad Dis Weekly Rep 1989; 17:33–40.
  • Buchwald D. Cheney PR, Peterson DL, Henry B, Wormsley SB, Geiger A, Ablashi DV, Salahuddin SZ, Saxinger C, Biddle R, Kikinis R, Jolesz FA, Folks T, Balachandran N, Peter JB, Gallo RC, Komaroff AL. A chronic illness character-ized by fatigue, neurologic and immunologic disorders, and active human herpes-virus type 6 infection. Ann Int Med 1992; 116:103–13,
  • Komaroff AL. Chronic fatigue syndromes: relationship to chronic viral in-fections. J Virol Methods 1988; 21:3–10.
  • Krueger GRF, Ablashi DV, Gallo RC. Persistent herpesvirus infections. Current techniques for diagnosis. J Virol Methods 1988; 21:1–326.
  • Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12:189–98.
  • Krueger GRF, Ablashi DV, Josephs SF, Salahuddin SZ, Lembke U, Ramon A, Bertram G. Clinical indication and diagnostic techniques of human herpesvi-rus-6 (11HV-6) infection. In Vivo 1991; 5:287–96.
  • Pearson GR. Recommended procedures for the diagnosis of persistent ac-tive herpesvirus infections. J Virol Methods 1988; 21:291–300.
  • Klotmann ME, Lusso P. Bacchus D, Corbellino M, Jarret RF, Berneman ZN. Detection of human herpesvirus-6 and human herpesvirus-7 by PCR amplifi-cation. In: Persing DH, Smith IF, Tenover FC, White Ti. Diagnostic Molecular Biology. Washington DC: Amer Soc Microbiol, 1993, 501–10.
  • Lasch JA, Klussmann JP, Krueger GRF. Die humanen Herpesviren 6 und 7. Hautarzt 1996; 47 (in press).
  • Griffith PD. Chronic cytomegalovirus infection. I Virol Methods 1988; 21: 79–86.
  • Christian CL. Uncommon illnessess from common infections. Trans Am Clin Climatol Assoc 1987; 99:111–8.
  • Straus SE. The chronic mononucleosis syndrome. J Infect Dis 1988; 157: 405–12.
  • Klimas NO. Immunopathogenesis of chronic fatigue syndrome. Presenta-tion, First World Congr Chronic Fatigue Syndrome and Related Disorders, Brus-sels, Nov 20, 1995.
  • Dylewski J, Chou S. Mcrigan IC. Absence of detectable IgM antibody during cytomegalovirus disease in patients with AIDS. N Engl J Med 1985; 309: 493.
  • Hilgers A, Frank J. Chronic fatigue immune dysfunction syndrome bei 103 Patienten: Diagnostik, Befunde und Therapie. Z KIM Med 1994; 47:152–64.
  • Krueger GRF, Klueppelberg U, Hoffmann A, Ablashi DV. Clinical corre-lates of infection with human herpesvirus-6. In Vivo 1994; 8:457–86.
  • Asano Y, Yoshikawa T, Kajita Y. Fatal encephalitis/encephalopathy in pri-mary human herpesvirus type 6 infection. Arch Dis Child 1992; 67:1484–5.
  • Caserta MT, Hall CB, Schnabel K. Neuroinvasion and persistence of hu-man herpesvirus 6 in children. J Infect Dis 1994; 170:1586–9.
  • Challoner PB, Smith KT, Parker JD. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Nat) Acad Sci USA 1995; 92:7440–4.
  • Di Luca D, Zorzenon M, Mirandola P, Colle R, Botta G, Cassai E. Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome. J Clin Micro-biol 1995; 33:1660–1.
  • Drobyski WR, Kehl-Knox K, Majewski D, Carrigan DR. Fatal encephalitis due to variant B human herpes virus 6 infection in a bone marrow transplant recip-ient. N Engl J Med 1994; 330:1356–60.
  • Jones CM, Dunn FIG, Thomas EE, Cone RW, Weber JM. Acute encephalo-pathy and status epilepticus associated with human herpesvirus-6 infection. Dev Med Child Neurol 1994; 36:646–50.
  • Kehl-Knox K, Carrigan DR. Active human herpesvirus 6 (HHV-6) infec-tion of the central nervous system in patients with AIDS.1 Acquir Immune Defic Syndr Hum Retrovirol 1995; 9:69–73.
  • Komaroff AL, Gupta S, Salit IE. Post-viral chronic fatigue syndrome. In: Ablashi DV, Krueger GRF, Salahuddin SZ. Human Herpesvirus-6. Epidemiology, molecular biology and clinical pathology. Amsterdam: Elsevier Sci Publ, 1992, 235–53.
  • Kondo K, Nagafuji H, Hata A, Tomomori C, Yamanishi K. Association of human herpesvirus-6 infection of the central nervous system with recurrence of febrile convulsions. J Infect Dis 1993; 167:1197–2000.
  • Saito Y, Sharer LR, Dewhurst S, Blumberg BM, Bresse Hall C, Epstein LG. Cellular localization of human herpesvirus-6 in the brains of children with AIDS encephalopathy. J Neurovirol 1995; 1:30–9.
  • Wakefield D, Lloyd A, Dwyer 1, Salahuddin SZ, Ablashi DV. Human her-pesvirus-6 and myalgic encephalomyelitis. Lancet 1989; 1: 1059.
  • Wilbom F, Schmidt C, Brinkmann V, Jendroska K, Oettle H, Siegert W. A potential role for human herpesvirus type 6 in nervous system disease. J Neuroim-munol 1994; 49:213–4.
  • Buchwald D. Laboratory abnormalities in chronic fatigue syndrome. In: Jenkins R, Mowbray J. Post-viral fatigue syndrome. Chichester: J Wiley Sons, 1991: 117–36.
  • Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormal-ities in chronic fatigue syndrome. J Clin Microbiol 1990; 28:1403–10.
  • Morrison LJA, Behan WHM, Behan PO. Changes in natural killer cell phe-notype in patients with post-viral fatigue syndrome. Clin Exp Immunol 1991; 83: 441–6.
  • Tosato G, Straus SE, Henle W, Pike SE, Blaese RM. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol 1985; 134:3082–8.
  • Buchwald D, Wener MH, Komaroff AL. Anti-neuronal antibody levels in chronic fatigue syndrome patients with neurologic abnormalities. Arthritis Rheum 1991; 34:1485–6.
  • Demitrak MA. The neuroendocrinology of chronic fatigue syndrome: bridging behavior and biology. Intemat Meetg Chronic Fatigue Syndrome, Dublin May 1994 (book of abstracts):18–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.